Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03914846 · ClinicalTrials.gov registry record · NA
Ultrasound in Diagnosing Patients With Skin Lesions
A NA study of Skin Lesion, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT03914846: Completed NA study of Skin Lesion, sponsored by Emory University.
NCT03914846 is a NA study of Skin Lesion that has completed, run by Emory University. The registered enrollment target is 47 participants, below the 1,783-participant average among 3 other Skin Lesion trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03914846, a NA study of Skin Lesion, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the use of a novel non-invasive ultrasound technique in diagnosing patents with skin lesions. Diagnostic procedures, such as ultrasound, may be a less invasive way to check skin lesions for skin cancer and other skin disorders.
Primary Outcome
Ultrasound findings will be reviewed for changes in lesions.
Conditions Studied
Interventions
- PROCEDURE Ultrasound
Study Locations (1)
Georgia
- Emory University Hospital/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2019-04-29 |
| Est. Completion | 2022-10-20 |
| Phase | NA |
What the finished NCT03914846 record still lists
NCT03914846 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,783-participant average among 3 other Skin Lesion trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Skin Lesion appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT03914846 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03914846 about?
NCT03914846 is a clinical study titled "Ultrasound in Diagnosing Patients With Skin Lesions". This trial studies the use of a novel non-invasive ultrasound technique in diagnosing patents with skin lesions. Diagnostic procedures, such as ultrasound, may be a less invasive way to check skin lesions for skin cancer and other skin disorders.
What is the current status of trial NCT03914846?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2019-04-29. Estimated completion is 2022-10-20.
What conditions does trial NCT03914846 study?
This clinical trial studies the following conditions: Skin Lesion.
What interventions are being tested in trial NCT03914846?
The interventions under investigation include: Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT03914846?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03914846 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI